You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Migalastat for treating Fabry disease

  • Highly specialised technologies guidance
  • Reference number: HST4
  • Published:  22 February 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

.

  • Evaluation consultation document (PDF 285 KB)

    Published:
    18 October 2016
  • Committee papers (PDF 7.69 MB)

    Published:
    18 October 2016

This page was last updated: 18 October 2016

Back to top